Category: Hepatitis
Global Hepatitis
-
Global Travel Vaccines Market Size Study, by Type (Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, Recombinant Vector Vaccines, Subunit Vaccines, Toxoid Vaccines), by Disease (DPT, Hepatitis A, Hepatitis B, Japanese Encephalitis, Measles and Mumps, Meningococcal, Rabies, Typhoid, Varicella, Yellow Fever), and Regional Forecasts 2024-2032
... Meningococcal, Rabies, Typhoid, Varicella, Yellow Fever), and Regional Forecasts 2024-2032 Global Travel Vaccines Market is valued at approximately USD 8.26 billion in 2023 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Antiviral Therapeutics Market Size Study, By Drug (Hepatitis, Herpes, HIV, Influenza), By Therapy (DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Protease Inhibitors, Reverse Transcriptase Inhibitors), By Distribution Channel (Hospital Pharmacy, Independent Pharmacy & Drug Store, Online Pharmacy), and Regional Forecasts 2022-2032
... Pharmacy), and Regional Forecasts 2022-2032 The Global Antiviral Therapeutics Market is valued approximately at USD 75.53 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.28% over the ... Read More
-
DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
... 2029 The global DNA diagnostics market is valued at an estimated USD 13.3 billion in 2024 and is projected to reach USD 21.2 billion by 2029, at a CAGR of 9.7% during the forecast period. ... Read More
-
2024 Global: Hepatitis C Virus (Hcv) Testing Market - Innovative Markets Forecast (2030) report
... and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Global Hepatitis B Therapeutics Market 2024-2028
... hepatitis B therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Hepatitis B Vaccines Competitive Landscape Professional Research Report 2024
... The vaccines work by stimulating the immune system to produce antibodies that provide immunity to the virus. Hepatitis B is commonly transmitted through contact with infected blood, unprotected sexual activity, or from an infected mother ... Read More
-
Travel Vaccines Market by Type (Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines), Disease (DPT, Hepatitis A, Hepatitis B) - Global Forecast 2024-2030
... expected to reach USD 9.09 billion in 2024, at a CAGR 10.06% to reach USD 16.18 billion by 2030. The travel vaccines market encompasses the production, distribution, and administration of immunizations recommended or required for ... Read More
-
RNA Interference Technology Market by Type (dsRNA, miRNA, siRNA), Therapeutics (Autoimmune Hepatitis, Hepatitis B and C, Neurological Disorders), Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 39.25 billion in 2024, at a CAGR 22.38% to reach USD 135.40 billion by 2030. The RNA interference (RNAi) technology market encompasses systems that use small RNA molecules ... Read More
-
Hepatitis B Vaccine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 8.38 billion in 2023, and the market is now projected to grow from to USD 8.85 billion in 2024 to USD 13.31 billion by 2032, exhibiting a CAGR of 5.2% during the ... Read More
-
Global Hepatitis B Vaccines Market Research Report 2024
... of 6.45% during the forecast period 2024-2030. North American market for Hepatitis B Vaccines is estimated to increase from $ 568 million in 2023 to reach $ 964 million by 2030, at a CAGR of ... Read More
-
2024 Global Forecast for Hepatitis C Virus (Hcv) Testing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
Global Hepatitis Diagnostic Test Databank Market Report
... 2023 to 2031. Blood tests segment is expected to be the highest contributor to this market, with $2,457.2 Million in 2022, and is anticipated to reach $3,721.6 Million by 2031, registering a CAGR of 4.76%. ... Read More
-
Global Hepatitis A Vaccine Market Analysis and Forecast 2024-2030
... age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally" 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric ... Read More
-
Global Hepatitis A Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
... HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are ... Read More
-
Global Hepatitis A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. ... Read More
-
Global Hepatitis A Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines ... Read More
-
Global Immunodiagnostics Market Size Study & Forecast, by Product (Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, Others), By End user (Clinical Laboratories, Hospitals, Physician’s Offices, Others), and Regional Analysis, 2023-2030
... and Regional Analysis, 2023-2030 Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2023-2030. Immunodiagnostics ... Read More
-
Vaccines Market By Technology Type (Recombinant and Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others), By Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, and Rubella, Diphtheria, Pertussis, and Tetanus (DTP), Polio, Hepatitis, Other Indications), By End User (Pediatric, Adults, Travelers): Global Opportunity Analysis and Industry Forecast, 2024-2035
... and Tetanus (DTP), Polio, Hepatitis, Other Indications), By End User (Pediatric, Adults, Travelers): Global Opportunity Analysis and Industry Forecast, 2024-2035 The vaccine market was valued at $43.2 billion in 2023 and is projected to reach ... Read More
-
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Growth 2024-2030
... US$ million in 2023. With growing demand in downstream market, the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
Global Hepatitis B Treatment Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Hepatitis B Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Prophylactic Hepatitis B Virus Vaccines Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Prophylactic Hepatitis B Virus Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Infectious Vaccines Market Size, Trends, Analysis, and Outlook By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Vaccines market size is poised to register 6.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Specialty Generics Market Size, Trends, Analysis, and Outlook By Type (Injectables, Oral drugs, Others), By Application (Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, Others), By End-user (Specialty pharmacy, Retail pharmacy, Hospital pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Specialty Generics market size is poised to register 11.48% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Antiviral Drugs Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Class, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antiviral Drugs market size is poised to register 4.55% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028
... The point of care diagnostics market is epected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion at a CAGR of 9.4% during the forecast period (2023–2028).The gobal rising burden of ... Read More
Research Assistance
